VerifiedBiotechnology Research· Founded 2015

Context Therapeutics

Context Therapeutics Inc.(Nasdaq: CNTX) is a biopharmaceutical company advancing T cell engaging ("TCE") bispecific antibodies for solid tumors. Context is building an innovative portfolio of TCE bispecific therapeutics, including CTIM-76, a Claudin 6 x CD3 bispecific antibody, CT-95, a Mesothelin x CD3 bispecific antibody, and CT-202, a Nectin-4 x CD3 bispecific antibody. Context is headquartered in Philadelphia. For more information, visit

7-day free trial · no credit card

Philadelphia, United States27(11 to 50)$10M to <$50M2015contexttherapeutics.com LinkedIn

Verified contacts

18

available on Kipplo

LinkedIn employees

27

11 to 50 range

Open roles

—

no listings

Distinct roles

9

indexed titles

Tech stack

2

tools in use

Monthly traffic

—

organic / mo

Sign up free to see all 18 verified contacts at Context Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

18 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 7 of 18 verified contacts

Top roles at Context Therapeutics

9 distinct titles indexed · top 9 shown.

2clinical trial associate
2senior scientific advisor
1associate director, accounting
1ceo and director
1chief financial officer
1senior director of quality
1sr director, program management and product lead
1vice president clinical operations context therapeutics
1vice president, clinical operations

Sign up to unlock all 18 contacts at Context Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 18 verified contacts at Context Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Context Therapeutics | Kipplo Discover